This year's sold-out conference had engaging discussions, talks from submitted abstracts, and opportunities to collaborate with experts from across the globe. There was also the opportunity to debate provocative early detection challenges.
Keynote Presentations and Highlights
The conference featured keynote presentations on:
- Population and tumor heterogeneity in cancer genome science - Speaker: John Carpten, USC
- Emerging technologies for early detection and precision diagnosis
- Multi-cancer early detection tests - Panel discussion with leading experts
- Funding agency perspectives - Insights from major research funders
Notable Sessions and Speakers
Day 1 highlights included:
- From models to mechanisms to humans - Topic chairs: Simon Leedham & Victor Velculescu
- Panel: How should we evaluate Multi Cancer Early Detection Tests? - Moderator: Michelle Le Beau
- Great Debate: "There is no such thing as over-diagnosis" - Speakers: Nora Pashayan & Eithne Costello
Day 2 featured:
- Opening remarks by Tanya Stoyanova, Canary Center at Stanford University
- Microbiological risk factors for early detection - Including gut microbiota research
- Panel on unexpected trial results and learning opportunities
- Great Debate: "Single-organ vs. Multi-cancer screening" - Speakers: Paul Limburg & Bob Steele
Breakthrough Research Presentations
Selected abstract presentations included:
"Mathematical Tools for Spatial Analysis of Multiplex Medical Images" - Joshua Bull
"Acoustic Fabrication of Living Cardiomyocyte-based Hybrid Biorobots" - Jie Wang
"A New Organ-on-Chip Platform to Study Gut Microbiota and Distal Tumors" - Danielle Brasino
The sold-out status of EDx22 demonstrates the growing importance and interest in early cancer detection research worldwide.